Mode
Text Size
Log in / Sign up

Elevated neutrophil-to-lymphocyte ratio correlates with disease activity in patients with systemic lupus erythematosusNeutrophil Levels Linked to Activity in Lupus Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that elevated neutrophil-to-lymphocyte ratio correlates with SLE disease activity and SLEDAI scores.

This meta-analysis evaluates the association between the neutrophil-to-lymphocyte ratio (NLR) and disease activity in patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN). The analysis included 4,006 SLE patients and 2,576 healthy controls across various ethnic groups, including European, Asian, and Arab populations.

The meta-analysis found that SLE patients exhibited significantly higher NLR compared to healthy controls (SMD = 1.051, 95% CI = 0.817-1.286, p < 0.001). This trend was consistent across specific subgroups: European (SMD = 1.058, p = 0.002), Asian (SMD = 1.058, p < 0.001), and Arab (SMD = 1.127, p < 0.001) populations. Furthermore, patients with active SLE showed significantly higher NLR than those with inactive SLE (SMD = 1.134, p = 0.012).

NLR demonstrated a significant positive correlation with the SLE Disease Activity Index (SLEDAI) (correlation coefficient = 0.354, p < 0.001). This correlation was also observed in Asian (0.358) and Arab (0.525) populations. However, no statistically significant difference in NLR was found between active LN and non-LN patients (p = 0.074).

Clinically, NLR is associated with disease activity in SLE and correlates with SLEDAI. However, the association does not imply causality, and NLR should not be used as a standalone diagnostic tool for SLE activity.

How this fits prior evidence

This meta-analysis addresses a gap in identifying objective biomarkers for monitoring disease activity in systemic lupus erythematosus. While previous coverage noted the prevalence of metabolic syndrome and the impact of depressive symptoms in lupus patients, this finding provides evidence that the neutrophil-to-lymphocyte ratio (NLR) correlates with SLEDAI scores and identifies higher systemic inflammation in active disease states.

Researchers analyzed data from over 4,000 people with systemic lupus erythematosus (SLE) and 2,500 healthy individuals. They looked at the neutrophil-to-lymphocyte ratio (NLR), which is a way to measure certain types of white blood cells in the blood. The study found that people with lupus had significantly higher NLR levels compared to healthy people across various regions, including Europe, Asia, and the Arab world.

The results showed a link between these blood cell levels and the actual activity of the disease. Specifically, patients with active lupus had higher levels than those with inactive lupus. The study also found a positive correlation between these levels and a standard score used to measure lupus severity. However, no significant difference was found specifically for those with lupus nephritis.

It is important to note that this study shows a link, not a cause. While these blood markers may help doctors track disease activity, they are not a standalone tool for diagnosis. Because this is a large-scale review of existing data, it provides a broad overview of trends rather than a new treatment. Patients should talk to their doctors about how these markers might relate to their specific care plan.

What this means for you:
Higher white blood cell ratios are linked to increased disease activity in patients with systemic lupus.

Common questions

What is the neutrophil-to-lymphocyte ratio (NLR)?

The NLR is a measurement of the ratio between two types of white blood cells: neutrophils and lymphocytes. This study found that patients with systemic lupus erythematosus (SLE) had significantly higher NLR levels than healthy individuals. These levels were also higher in patients with active SLE compared to those with inactive SLE.

Can this blood test tell if my lupus is active?

The study found a significant positive correlation between the NLR and the SLE Disease Activity Index (SLEDAI). This means higher levels are linked to more active disease. However, the study does not suggest using this as a standalone diagnostic tool. You should consult your doctor to interpret these results.

Does this finding apply to all types of lupus?

The study found that higher NLR levels were linked to active disease in general SLE patients. However, the researchers did not find a statistically significant difference in NLR levels specifically between patients with active lupus nephritis and those without it.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedNov 2026
View Original Abstract ↓
ObjectiveThis study aimed to assess the relationship between the neutrophil-to-lymphocyte ratio (NLR) and systemic lupus erythematosus (SLE), with specific focus on the association between NLR and disease activity, including lupus nephritis (LN), and evaluating the correlation between NLR and the SLE Disease Activity Index (SLEDAI).MethodsA systematic search of MEDLINE, Embase, and Web of Science from database inception through August 2025 was conducted. Meta-analyses compared NLR values between SLE patients and healthy controls, between active and inactive SLE, and between active LN and non-LN subgroups, with stratification by ethnicity, sample size, and publication year. Correlation coefficients between NLR and SLEDAI were pooled to assess the strength of this association.ResultsThirty-one studies comprising 4,006 SLE patients and 2,576 healthy controls were included. The combined analysis showed significantly increased NLR in SLE patients versus controls (SMD = 1.051, 95% CI = 0.817-1.286, < 0.001). Significantly higher NLR was observed in European, Asian, and Arab SLE patients relative to healthy controls within each respective subgroup, by showing significantly higher NLR in European (SMD = 1.058, 95% CI = 0.402-1.713, = 0.002), Asian (SMD = 1.058, 95% CI = 0.839-1.278, < 0.001), and Arab (SMD = 1.127, 95% CI = 0.707-1.547, < 0.001) populations. Comparing disease activity, active SLE patients had notably higher NLR than those with inactive disease (SMD = 1.134, 95% CI = 0.252-2.017, = 0.012). However, the difference in NLR between active LN and non-LN groups was not statistically significant (SMD = 0.467, 95% CI = -0.045-0.979, = 0.074). NLR showed a significant positive correlation with SLEDAI (correlation coefficient = 0.354, 95% CI = 0.256-0.444, < 0.001). Subgroup analysis revealed significant correlations in Asian (correlation coefficient = 0.358, 95% CI = 0.246-0.461, < 0.001) and Arab (correlation coefficient = 0.525, 95% CI = 0.382-0.644, < 0.001) populations.ConclusionsThis meta-analysis demonstrates that NLR is significantly increased in SLE patients compared to healthy controls, and that NLR is associated with greater disease activity, supported by its positive correlation with SLEDAI.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.